AR019936A1 - Procedimiento para preparar acidos quinolon y naftiridon carboxilicos y procedimiento para preparar trovafloxacina - Google Patents

Procedimiento para preparar acidos quinolon y naftiridon carboxilicos y procedimiento para preparar trovafloxacina

Info

Publication number
AR019936A1
AR019936A1 ARP990103700A ARP990103700A AR019936A1 AR 019936 A1 AR019936 A1 AR 019936A1 AR P990103700 A ARP990103700 A AR P990103700A AR P990103700 A ARP990103700 A AR P990103700A AR 019936 A1 AR019936 A1 AR 019936A1
Authority
AR
Argentina
Prior art keywords
formula
quinolon
prepare
procedure
compound
Prior art date
Application number
ARP990103700A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR019936A1 publication Critical patent/AR019936A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Quinoline Compounds (AREA)

Abstract

Se trata de la preparacion de ácidos quinolon y naftiridonacarboxílicos antibacterianos, que tienen un grupo amino externo ligado mediante un miembro depuente a la estructura ciclica, en posicion 7 sin la utilizacion y la posterior eliminacion, de grupos bloqueantes en el grupo amino externo. Dichos ácidosquinolon y naftiridinquinolona, responden a la formula (1) o una sal bipolar del mismo, que comprende la etapa de poner en contacto, en presencia de una basede amina terciaria: (a) un compuestode formula (2) en la que A es CH, CF, CCl, COCH3, CCH3, CCN o N; Y, cuando se toma independientemente, es etilo,t-butilo, vinlilo, ciclopropilo, 2-fluoroetilo, p-fluorofenilo u o,p-difluorofenilo; o A es un átomo de C y se toma junto con Y, los átomos de C y nitrogeno alos que están unidos A e Y forman un anillo de 5-6 miembros que puede contener oxígeno o un doble enlace, y que puede tener metilo o metileno unido al anillo;W es H, F, Cl, Br, alquilo C1-4, alcoxi C1-4, amino o NHCH3; y X es halogeno, con (b) un compuesto de formula: HR1(CH2)aNH2(ZH)b (3) donde R1 es un grupoamino secundario cíclico que tiene un átomo de nitrogeno necleofilo; ZH es un ácido; a es 0 o 1; y b varía entre 1 y el numero de átomos de nitrogeno básicosen el compuesto de formula (3).En una realizacion preferida se trata de la preparacion de trovafloxacina, un ácido naftiridincarbaxílico de formula (1), depropiedades antibioticas.
ARP990103700A 1998-07-28 1999-07-27 Procedimiento para preparar acidos quinolon y naftiridon carboxilicos y procedimiento para preparar trovafloxacina AR019936A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9444098P 1998-07-28 1998-07-28

Publications (1)

Publication Number Publication Date
AR019936A1 true AR019936A1 (es) 2002-03-27

Family

ID=22245218

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103700A AR019936A1 (es) 1998-07-28 1999-07-27 Procedimiento para preparar acidos quinolon y naftiridon carboxilicos y procedimiento para preparar trovafloxacina

Country Status (17)

Country Link
US (1) US6114531A (es)
EP (1) EP0976749A1 (es)
JP (1) JP2000053646A (es)
KR (1) KR100343356B1 (es)
CN (1) CN1247865A (es)
AR (1) AR019936A1 (es)
AU (1) AU4116999A (es)
BR (1) BR9903003A (es)
CA (1) CA2278845C (es)
HU (1) HUP9902548A3 (es)
ID (1) ID25767A (es)
IL (1) IL131040A0 (es)
PL (1) PL334621A1 (es)
RU (1) RU2167867C2 (es)
TR (1) TR199901796A2 (es)
YU (1) YU35599A (es)
ZA (1) ZA994814B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
CN1297542C (zh) * 2003-12-28 2007-01-31 柯保桂 6-氟-1,4-二氢-4-氧代喹啉-3-羧酸衍生物的制备
US7759362B2 (en) * 2004-04-21 2010-07-20 Institut Of Medicinal Biotechnology Chinese Academy Of Medical Sciences Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
CN1244582C (zh) * 2004-04-21 2006-03-08 中国医学科学院医药生物技术研究所 喹诺酮羧酸类化合物及其制备方法和医药用途
US7902227B2 (en) * 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU553415B2 (en) * 1983-09-19 1986-07-17 Abbott Japan Co., Ltd. 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
EP0549857A1 (en) * 1991-12-31 1993-07-07 Korea Research Institute Of Chemical Technology Antibacterial quinolone carboxylic acid derivatives
WO1997007800A1 (en) * 1995-08-29 1997-03-06 Pfizer Inc. Zwitterionic forms of trovafloxacin
JPH09125546A (ja) * 1995-11-02 1997-05-13 Sekisui Chem Co Ltd 二重断熱部材
JPH09208578A (ja) * 1996-02-07 1997-08-12 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体およびそれを有効成分とする抗ピロリ菌剤

Also Published As

Publication number Publication date
BR9903003A (pt) 2000-03-21
ZA994814B (en) 2001-01-29
JP2000053646A (ja) 2000-02-22
US6114531A (en) 2000-09-05
CA2278845A1 (en) 2000-01-28
CN1247865A (zh) 2000-03-22
HUP9902548A2 (hu) 2000-05-28
KR20000012002A (ko) 2000-02-25
IL131040A0 (en) 2001-01-28
AU4116999A (en) 2000-02-17
KR100343356B1 (ko) 2002-07-15
HU9902548D0 (en) 1999-10-28
CA2278845C (en) 2003-07-08
RU2167867C2 (ru) 2001-05-27
TR199901796A2 (xx) 2000-02-21
EP0976749A1 (en) 2000-02-02
PL334621A1 (en) 2000-01-31
ID25767A (id) 2000-11-02
HUP9902548A3 (en) 2001-01-29
YU35599A (sh) 2002-11-15

Similar Documents

Publication Publication Date Title
CY1113330T1 (el) Υποκατεστημενες με φθοριο κυκλοαλκανοϊνδολες και η χρηση τους ως ανταγωνιστες των υποδοχεων προσταγλανδινης d2
DK1673338T3 (da) Forbindelser afledt af fedtsyrer, fremstilling og anvendelse
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
CY1111693T1 (el) Αντιιικοι παραγοντες
EA200201179A1 (ru) Производные 2-аминокарбонил-9h-пурина
ES2132351T3 (es) Compuestos con un grupo sulfamoilo y amidino, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ID23991A (id) Turunan-turunan sulfonil
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
DK0455510T3 (da) Anvendelse af 5HT1A-receptoragonist til inhibering af mavesyresekretion
GB0128499D0 (en) Therapeutic agents
ES2062706T3 (es) Nuevos derivados de amino-metil-piperidina su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
CY1110502T1 (el) Αντιμυκητικες 4-υποκατεστημενες 5,6-διϋδρο-4η-πυρρολο[1,2-α][1,4]βενζοδιαζεπινες
HRPK20040372B3 (en) Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist
NO306510B1 (no) Androsteroner, anvendelse derav og farmasöytisk formulering
EA200200489A1 (ru) Новые соединения бензотиадиазина, способ их получения и содержащие их фармацевтические композиции
AR019936A1 (es) Procedimiento para preparar acidos quinolon y naftiridon carboxilicos y procedimiento para preparar trovafloxacina
EA200300392A1 (ru) Производные пиперазина с мостиковой связью
ES2131535T3 (es) Fotosensibilizadores.
FR2847899B1 (fr) Derives d'indole-3-carboxamide, leur preparation et leur application en therapeutique
MX9203452A (es) Derivados de 2-(piperidin-1-il)-etanol, su preparacion y su aplicacion en terapeutica.
ATE131478T1 (de) 4-((2-benzothiazolyl)methylamino>-alpha-(3,4- difluorphenoxy)methyl-1-piperidenethanol
HRP20080546T3 (en) Combination of an antagonist of the tp-receptors and clopidogrel
AR020587A1 (es) Metodo para la profilaxis o tratamiento de una infeccion bacteriana en mamiferos, uso de un inhibidor de oxido nitrico sintasa inducible para lafabricacion de medicamentos y formulacion farmaceutica
EA200501299A1 (ru) Замещенные производные анилина
EA200000116A1 (ru) Противогрибковые соединения на основе 2,4,4-тризамещенных-1,3-диоксоланов

Legal Events

Date Code Title Description
FB Suspension of granting procedure